Status:
COMPLETED
Weight Management Aimed to Reduce Risk and Improve Outcomes From Radical Prostatectomy
Lead Sponsor:
University of Kansas Medical Center
Collaborating Sponsors:
American Cancer Society, Inc.
Conditions:
Obesity
Prostate Cancer
Eligibility:
MALE
50+ years
Phase:
NA
Brief Summary
The purpose of this study is to test how a weight management program affects substances in the blood called biomarkers that can show the presence or severity of cancer, compared to a standardized diet...
Eligibility Criteria
Inclusion
- Men newly diagnosed with PCa who are scheduled for radical prostatectomy (RP) (T1 or T2)
- Body Mass Index (BMI) 25-45 kg/m2
- Has internet access
Exclusion
- History of 5 alpha reductase inhibitors prior 3 months
- History of radiation therapy for cancer treatment
- Taking active cancer treatment
- Undergoing salvage therapy
- Castration-resistant PCa
- Evidence of metastasis
- Evidence of biochemical recurrence
- High risk medical condition (e.g. kidney disease, uncontrolled diabetes, etc.)
Key Trial Info
Start Date :
November 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 25 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03261271
Start Date
November 2 2017
End Date
March 25 2025
Last Update
April 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160